{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:39Z","timestamp":1789524159335,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10557-026-07880-9","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:38:20Z","timestamp":1779421100000},"page":"2099-2100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reflections on Oral Beta Blocker Therapy and Long-term Outcomes after Myocardial Infarction in Preserved Left Ventricular Function"],"prefix":"10.1007","volume":"40","author":[{"given":"Reza","family":"Yaghoubi Nezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"7880_CR1","doi-asserted-by":"crossref","unstructured":"Sidiq SA, Truly TA, Minhas AMK et al. Association between oral beta blocker therapy and long-term outcomes after myocardial infarction in individuals with mildly reduced or preserved left ventricular function\u2013a meta-analysis of contemporary randomized controlled trials. Cardiovasc Drugs Ther. 2025;1\u20139.","DOI":"10.1007\/s10557-025-07826-7"},{"key":"7880_CR2","doi-asserted-by":"crossref","unstructured":"Oh S, Kim JH, Cho KH et al. Differential outcomes of Beta-Blockers according to heart rate following myocardial infarction with reduced left ventricular ejection fraction. Cardiovasc Drugs Ther. 2025;1\u201314.","DOI":"10.1007\/s10557-025-07791-1"},{"key":"7880_CR3","unstructured":"guideline NG185 N. (2020) Acute coronary syndrome."},{"key":"7880_CR4","doi-asserted-by":"crossref","unstructured":"Fordham M, Lyubarova R, Sidhu M. The beta-blocker dilemma: revisiting their role in cardiovascular disease. Cardiovasc Drugs Ther. 2025;1\u20133.","DOI":"10.1007\/s10557-025-07678-1"},{"key":"7880_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4266\/acc.2023.00955","volume":"38","author":"S-J Joo","year":"2023","unstructured":"Joo S-J. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38:251.","journal-title":"Acute Crit Care"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07880-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07880-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:29:28Z","timestamp":1789522168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07880-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["7880"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07880-9","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}